Drug-induced urinary retention: a real-world pharmacovigilance study using FDA and Canada vigilance databases.

Overall, reports of drug-related UR showed an increasing trend ( Table 2 ; Figure 1A ), with the highest number of reports in 2023 (1,397 cases, 8.63%).

also in 63,971 other papers

This finding is highly significant for drug safety monitoring and risk management, providing a scientific basis for improving drug labeling.

also in 132,142 other papers